We are pleased to announce that the T2Biothreat Panel has received 510(k) clearance from the FDA. This biothreat panel is the first and only FDA-cleared product able to simultaneously detect these six high-priority biothreat pathogens. ow.ly/yMpu50PNfB4
T2 Biosystems
2,118 posts
T2 Biosystems is dedicated to saving lives and reducing the cost of healthcare by empowering clinicians to effectively treat patients faster than ever before.
- In a #publichealth emergency involving #biothreat pathogens, rapid and accurate diagnostic testing is expected to play a central role in achieving targeted antimicrobial treatment, improving patient outcomes, and minimizing economic impact. #T2Biothreat ow.ly/ALBF50PNglv
- Target therapy sooner with species ID before the second dose of empiric therapy. The FDA-cleared T2Bacteria and T2Candida Panels provide identification of deadly bacterial and fungal pathogens independent of blood culture. #sepsis Learn more at t2biosystems.com
00:00 - The #T2Biothreat Panel is a direct-from-blood molecular dx test that runs on the T2Dx Instrument & simultaneously detects six #biothreat pathogens, including the organisms that cause anthrax, tularemia, glanders, melioidosis, plague, and typhus. ow.ly/tYTu50PNgss
- Today is #WorldSepsisDay, and at T2 Biosystems, we are committed to raising awareness for the global healthcare burden of #sepsis. #GlobalSepsisAlliance #SepsisAwarenessMonth #SepsisAwareness #SepsisAlliance ow.ly/ScgH50PArsY
- We are proud to announce the U.S. launch of our new molecular diagnostic test, the T2SARS-CoV-2 Panel, which has demonstrated excellent clinical performance in the detection of SARS-CoV-2, the virus responsible for #COVID19! bit.ly/2YLJPMd
- New CDC data identified opportunities to improve hospital sepsis programs, so patients receive faster and better care. Learn more: bit.ly/SepsisCoreElem…t2biosystems.gcs-web.comT2 Biosystems Praises CDC’s Actions Aimed at Optimizing U.S. Hospital Sepsis Programs | T2 Biosys...The Investor Relations website contains information about T2 Biosystems Inc. 's business for stockholders, potential investors, and financial analysts.
- In honor of #SepsisAwarenessMonth, @SepsisAlliance encourages everyone to learn the signs of sepsis. As many as 80% of sepsis deaths could be prevented with early detection and treatment. Learn more at SepsisAwarenessMonth.org. #SAM2023
- This article showcases T2Bacteria and T2Candida clinical user Dr. Robert Patterson and his team at #ButlerMemorialHospital and how they utilize T2 Biosystems panels in their lab alongside other cutting-edge technologies. #sepsis #diagnostics
- Come meet the T2 Team at booth 5 during #SWACM to learn more about species identification direct from whole blood! #Sepsis #SWACM #Microbiology #Lab #Diagnostics
- September is #SepsisAwarenessMonth. Sadly, in the 20 seconds it takes you to read this post, another person in the United States will be diagnosed with #sepsis. @SepsisAlliance is asking everyone to take the TIME to save a life. Learn more at SepsisAwarenessMonth.org. #SAM2023
- During this #webinar, Dr. Vrettou will provide insights into the clinical utility of T2 Sepsis Panels in the intensive care unit, including real-world clinical case studies. Register today! #sepsis #SepsisAwarenessMonth ow.ly/2rFm50PNTrLl
- Thank you to everyone that visited our virtual booth and attended the T2 Biosystems industry session during #SepsisAllianceSummit. The presentation is now available to view on-demand. #SepsisAlliance #Sepsis #SAM2023 #SepsisAwareness ow.ly/271M50PRkrc














